Bryonia alba 30c homeopathic tablets

Arnica L. genus (Asteraceae) comprises perennial herbs native to the temperate and boreal parts of the northern hemisphere. Arnica montana is the main species. It shows different biological activities, such as antioxidant, anti-inflammatory, antibacterial, antifungal, and antitumor effects. The Arnica formulations are mainly used for pain management. This systematic review is aimed at summarizing the studies focusing on the use of Arnica products on pain and inflammatory signs due to traumatic injuries related to sport and surgical interventions as well as to arthritis and other inflammatory conditions. Both phytotherapeutic and homeopathic formulations are taken into account. This paper only includes manuscripts published in mainstream journals. A literature search from Scopus, Web of Science, and PubMed databases has been carried out using a combination of the keywords "Arnica", "trauma", "sport", "injury", "injuries", and "pain". According to the search strategy and inclusion criteria for this study, 42 eligible papers, focusing on both Arnica alone and formulations containing a mixture of plant extracts, have been finally selected. This review critically discusses the in vitro, in vivo, and clinical studies dealing with Arnica products, reporting both positive and negative outcomes, thus providing perspectives for future research on the plant pharmacological potential.

Abstract licence: CC BY

Background: Brazil has had one of the highest numbers of cases and deaths from coronavirus disease 2019 (COVID-19) worldwide. Objectives: This study aimed to investigate the association between COVID-19 influenza-like symptoms and the use of a homeopathic medicine Bryonia alba 30cH, China officinalis 30cH and Metallum album 30cH during the pandemic in Brazil. Methodology: An observational, longitudinal, cohort study was conducted in Duque de Caxias, Rio de Janeiro, from May to June 2020. Participants were divided into two groups with or without COVID-19 influenza-like symptoms, who received the homeopathic medicine. The primary endpoint was the number of COVID-19 influenza-like symptoms. Secondary measures were the number of hospital admissions, adverse events, and improvements in general health symptoms reported by the participants. Results: Data from 51 families (128 participants) were analysed and showed no statistically significant difference in the severity of illness in the previously sick and healthy groups (p < 0.05). Although, secondary outcome showed that a high percentage of participants (98.03%) reported having had general health symptoms' improvements (84.31%) and none reported adverse events. Despite the previous comorbidities in 52.9% of the families and considering that COVID-19 infected 1.96%, only 0.098% sought for medical assistance and none needed hospitalisation. Conclusions: no differences were found between the previous sick and healthy groups after homeopathy intervention. However, data showed that homeopathic medicine was safe and promoted improvements in general health symptoms. Results reinforce the need for further randomised controlled trials, in the knowledge that homeopathy may offer a health promotion during epidemics.

Abstract licence: CC BY-NC-SA

Based on the widespread use of homeopathy in dairy farm practice when treating mastitis, a blind randomised controlled trial (RCT) was conducted to assess the effectiveness of homeopathic treatment of clinical mastitis on four dairy farms. The study considered specific guidelines for RCTs as well as the basic principles of individualised homeopathy and involved 180 lactating dairy cows. Evaluation of cure rates was based on clinical investigation of the udder and on laboratory analysis of milk samples. In culture-positive cases, the antibiotic treatment provided suboptimal bacteriological cures (60-81 per cent) but was more effective than individualised homeopathy (33-43 per cent) whose effects appeared little different to those of placebos (45-47 per cent) (P≤0.05). On the cytological cure level, all three treatment methods were similarly ineffective: antibiotic being 2-21 per cent, individualised homeopathy 0-8 per cent and placebo 3-13 per cent (P≤0.05; P=0.13). Antibiotics, individualised homeopathy and placebo had similar effects on bacteriological and cytological cure in cases of culture-negative milk samples (P>0.4) and Escherichia coli infections (P=1.0). The study results implied that the effectiveness of individualised homeopathy does not go beyond a placebo effect and successful treatment is highly dependent on the specific mastitis pathogen. Thus, antimicrobial or alternative remedies used should be based on the bacterial culture of the milk sample.Trial registration numberNTP-ID: 00008011-1-9, Pre-results.

Abstract licence: CC BY-NC